Esbjerg Hospital - University Hospital of Southern Denmark Clinical Trials
Sponsors / Esbjerg Hospital - University Hospital of Southern Denmark
53 ClinicalTrials.gov entries name Esbjerg Hospital - University Hospital of Southern Denmark as the lead sponsor. The portfolio currently includes 12 recruiting studies, 3 active non-recruiting studies, and 25 completed studies. 4 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 22,052 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
53
Total Trials
12
Recruiting
3
Other Active
25
Completed
4
Terminated / Withdrawn
22,052
Total Enrollment
Termination reasons: Other50% · Recruitment50%
Recent Terminations
- Prostate Cancer"Due to change of EAU guidelines, where PSMA-PET/CT is now recommended for primary staging of prostate cancer. We do not believe we ethically could continue this protocol, when the new examination, that was our intervention, is now the recom"
- COPD Exacerbation"Not possible to include patients at the required speed"
- Complex Regional Pain Syndrome Type I"Lack of recruitment"
- Arthritis, Rheumatoid"Slow recruitment due to COVID19."
Active Trials (3 total)
- NCT06896682
- NCT06297109
- NCT07361952
- NCT07353632
- NCT06790225
- NCT07162987
- NCT06219486
- NCT06882993
- NCT06289114
- Bariatric Surgery Candidate PHASE4NCT03721497
- NCT03535142
- Osteoporosis Secondary PHASE2NCT06421597
- NCT05062915
- NCT06182111
- NCT06222151